Aseptuva raised CHF 500’000 in a pre-seed round backed by Valuemaker AG and Fortyone AG Health services Investments 30 August 2022 Share: Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!
Round value (USD): 511k Round investors: Valuemaker AGFortyone AG Company: Aseptuva Industry: Health services
EVis Bioscience raised €740,000 on Capital Cell. Biotech Health services Pharma Investments 03 March 2026